Avidity Biosciences share price today
(NASDAQ: RNA)

Name: Avidity Biosciences Share Price Today (NASDAQ: RNA) - Avidity Biosciences Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Avidity Biosciences share price is $30.13 & ₹2,605.94 as on 24 Jan 2025, 2.30 'hrs' IST

$30.13

▲

0.05

(0.17%)

Market is closed - opens 8 PM, 24 Jan 2025

View live Avidity Biosciences share price in Dollar and Rupees. Guide to invest in Avidity Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Avidity Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Avidity Biosciences share price movements

Today's Low: $29.07
Today's High: $30.54
$30.13
3.52%
Downside
Day's Volatility :4.81%
Upside
1.34%
52 Weeks Low: $10.12
52 Weeks High: $56.00
$30.13
66.41%
Downside
52 Weeks Volatility :81.93%
Upside
46.2%

Avidity Biosciences Returns

Period	Avidity Biosciences Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-33.32%	-5.5%	0.0%
6 Months	-37.52%	-4.3%	0.0%
1 Year	187.3%	1.6%	0.0%
3 Years	100.4%	9.8%	-11.0%

Avidity Biosciences Key Statistics

in dollars & INR

Previous Close	$30.08
Open	$30.0
Today's High	$30.54
Today's Low	$29.07
Market Capitalization	$3.7B
Today's Volume	$1.2M
52 Week High	$56.0
52 Week Low	$10.12
Revenue TTM	$10.1M
EBITDA	$-322.0M
Earnings Per Share (EPS)	$-2.88
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-27.76%

How to invest in Avidity Biosciences Stock (RNA) from India?

It is very easy for Indian residents to invest directly in Avidity Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Avidity Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Avidity Biosciences or RNA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Avidity Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Avidity Biosciences shares which would translate to 0.029 fractional shares of Avidity Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Avidity Biosciences, in just a few clicks!

Returns in Avidity Biosciences for Indian investors in Rupees

Investment Value

₹1,00,000

Avidity Biosciences investment value today

Current value as on today

₹2,91,829

Returns

₹1,91,829

(+191.83%)

Returns from Avidity Biosciences Stock

₹1,87,775 (+187.77%)

Dollar Returns

₹4,054 (+4.05%)

Indian investors sentiment towards Avidity Biosciences

-74%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for Avidity Biosciences on INDmoney from India has reduced in the last 30 days as on Jan 24, 2025. -74% less investors are searching Avidity Biosciences in the last 30 days versus the previous period.

Global Institutional Holdings in Avidity Biosciences

FMR Inc
14.12%
T. Rowe Price Associates, Inc.
8.91%
BlackRock Inc
8.15%
Vanguard Group Inc
7.73%
RTW INVESTMENTS, LLC
6.82%
Wellington Management Company LLP
5.89%

Analyst Recommendation on Avidity Biosciences

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Avidity Biosciences(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Avidity Biosciences

What analysts predicted

Upside of 126.59%

Target:

$68.27

Current:

$30.13

Insights on Avidity Biosciences

Price Movement
In the last 3 months, RNA stock has moved down by -33.7%
Increasing Revenue
Revenue is up for the last 2 quarters, 2.04M → 2.33M (in $), with an average increase of 12.5% per quarter
Decreasing Net Profit
Netprofit is down for the last 6 quarters, -47.02M → -80.39M (in $), with an average decrease of 11.4% per quarter

Avidity Biosciences Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$379.0K	↓ 97.1%
Net Income	$-11.9M	-
Net Profit Margin	-3.1K%	-

	FY19	Y/Y Change
Revenue	$2.3M	↑ 511.87%
Net Income	$-32.1M	↑ 169.16%
Net Profit Margin	-1.4K%	↑ 1763.69%

	FY20	Y/Y Change
Revenue	$6.8M	↑ 192.67%
Net Income	$-44.0M	↑ 36.93%
Net Profit Margin	-648.03%	↑ 737.09%

	FY21	Y/Y Change
Revenue	$9.3M	↑ 37.41%
Net Income	$-117.4M	↑ 166.86%
Net Profit Margin	-1.3K%	↓ 610.49%

	FY22	Y/Y Change
Revenue	$9.2M	↓ 1.09%
Net Income	$-169.1M	↑ 44.05%
Net Profit Margin	-1.8K%	↓ 574.49%

	FY23	Y/Y Change
Revenue	$9.6M	↑ 3.64%
Net Income	$-212.2M	↑ 25.52%
Net Profit Margin	-2.2K%	↓ 386.86%

	Q2 FY23	Q/Q Change
Revenue	$2.3M	↑ 3.72%
Net Income	$-47.0M	↓ 0.35%
Net Profit Margin	-2.0K%	↑ 82.95%

	Q3 FY23	Q/Q Change
Revenue	$2.8M	↑ 21.68%
Net Income	$-52.4M	↑ 11.34%
Net Profit Margin	-1.9K%	↑ 172.46%

	Q4 FY23	Q/Q Change
Revenue	$2.2M	↓ 22.18%
Net Income	$-60.4M	↑ 15.44%
Net Profit Margin	-2.8K%	↓ 898.2%

	Q1 FY24	Q/Q Change
Revenue	$3.5M	↑ 61.56%
Net Income	$-68.9M	↑ 13.92%
Net Profit Margin	-1.9K%	↑ 812.77%

	Q2 FY24	Q/Q Change
Revenue	$2.0M	↓ 42.28%
Net Income	$-70.8M	↑ 2.81%
Net Profit Margin	-3.5K%	↓ 1518.35%

	Q3 FY24	Q/Q Change
Revenue	$2.3M	↑ 14.23%
Net Income	$-80.4M	↑ 13.57%
Net Profit Margin	-3.4K%	↑ 20.06%

	FY18	Y/Y Change
Profit	$379.0K	-

	FY19	Y/Y Change
Profit	$-12.2M	↓ 3324.27%

	FY20	Y/Y Change
Profit	$6.8M	↓ 155.54%

	FY21	Y/Y Change
Profit	$9.3M	↑ 37.41%

	FY22	Y/Y Change
Profit	$9.2M	↓ 1.09%

	FY23	Y/Y Change
Profit	$7.5M	↓ 19.13%

	Q2 FY23	Q/Q Change
Profit	$1.1M	↓ 8.58%

	Q3 FY23	Q/Q Change
Profit	$1.5M	↑ 43.89%

	Q4 FY23	Q/Q Change
Profit	$1.6M	↑ 3.95%

	Q1 FY24	Q/Q Change
Profit	$2.9M	↑ 83.9%

	Q2 FY24	Q/Q Change
Profit	$1.4M	↓ 53.2%

	Q3 FY24	Q/Q Change
Profit	$2.3M	↑ 72.02%

	FY18	Y/Y Change
Operating Cash Flow	$-9.7M	-
Investing Cash Flow	$-49.0K	-
Financing Cash Flow	$5.1M	↓ 94.16%

	FY19	Y/Y Change
Operating Cash Flow	$2.5M	↓ 125.79%
Investing Cash Flow	$-235.0K	↑ 379.59%
Financing Cash Flow	$89.2M	↑ 1634.7%

	FY20	Y/Y Change
Operating Cash Flow	$-37.1M	↓ 1590.64%
Investing Cash Flow	$-7.8M	↑ 3212.77%
Financing Cash Flow	$272.0M	↑ 204.86%

	FY21	Y/Y Change
Operating Cash Flow	$-94.8M	↑ 155.44%
Investing Cash Flow	$-82.5M	↑ 959.95%
Financing Cash Flow	$176.3M	↓ 35.19%

	FY22	Y/Y Change
Operating Cash Flow	$-136.3M	↑ 43.72%
Investing Cash Flow	$-190.0M	↑ 130.2%
Financing Cash Flow	$346.2M	↑ 96.34%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-49.8M	↑ 1.72%
Investing Cash Flow	$46.0M	↑ 0.0%
Financing Cash Flow	$39.0M	↑ 69.73%

Avidity Biosciences Technicals Summary

Sell

Neutral

Buy

Avidity Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Avidity Biosciences Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Avidity Biosciences Inc	-3.34%	-37.52%	187.3%	100.4%	34.23%
Biontech Se	0.91%	34.01%	18.85%	-26.4%	246.9%
Regeneron Pharmaceuticals, Inc.	-4.82%	-36.95%	-28.33%	12.74%	100.35%
Vertex Pharmaceuticals Incorporated	4.86%	-13.58%	-0.46%	88.45%	88.24%
Alnylam Pharmaceuticals, Inc.	9.57%	13.5%	44.91%	103.56%	127.75%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Avidity Biosciences Inc	NA	NA	0.0	-2.86	-0.28	-0.18	NA	12.64
Biontech Se	160.8	NA	0.04	-3.33	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	17.02	17.02	1.05	44.99	0.17	0.07	NA	272.04
Vertex Pharmaceuticals Incorporated	32.84	NA	1.1	0.48	-0.03	0.12	NA	60.65
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.18	-15.01	-0.03	NA	0.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Avidity Biosciences Inc	Buy	$3.7B	34.23%	NA	0.0%
Biontech Se	Buy	$28.1B	246.9%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$75.6B	100.35%	17.02	33.61%
Vertex Pharmaceuticals Incorporated	Buy	$110.2B	88.24%	32.84	-4.51%
Alnylam Pharmaceuticals, Inc.	Buy	$34.2B	127.75%	NA	-15.86%

Avidity Biosciences Dividend announcements

Avidity Biosciences Earnings
Avidity Biosciences’s price-to-earnings ratio stands at None
Read More

About Avidity Biosciences

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease that is in phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of duchenne muscular dystrophy, which is under phase 1/2 clinical development trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy that is in phase 1/2 clinical trial. The company is developing products for rare skeletal muscle and rare cardiac diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.

Organization	Avidity Biosciences
Employees	253
CEO	Dr. Troy Edward Wilson J.D., Ph.D.
Industry	Health Technology

Management People of Avidity Biosciences

Name	Title
Dr. Troy Edward Wilson J.D., Ph.D.	Co-Founder & Independent Chairman
Ms. Sarah Boyce	President, CEO & Director
Dr. W. Michael F. Flanagan Ph.D.	Chief Scientific Officer
Ms. Teresa McCarthy	Chief Human Resources Officer
Mr. Eric B. Mosbrooker	Chief Commercial Officer
Prof. Mark E. Davis Ph.D.	Scientific Founder, Member of Scientific Advisory Board and Member of Board of Managers
Dr. Frank P. McCormick Ph.D.	Scientific Founder & Member of Scientific Advisory Board
Mr. Charles Calderaro III	Chief Technical Officer
Mr. John B. Moriarty Jr., ESQ., J.D.	Chief Legal Officer & Corporate Secretary
Ms. Kathleen Gallagher	Chief Program Officer

Important FAQs about investing in Avidity Biosciences (RNA) from India :

What is Avidity Biosciences share price today?

Avidity Biosciences share price today stands at $30.13, Open: $30.00 ; Previous Close: $30.08 ; High: $30.54 ; Low: $29.07 ; 52 Week High: $56.00 ; 52 Week Low: $10.12. The stock opens at $30.00, after a previous close of $30.08. The stock reached a daily high of $30.54 and a low of $29.07, with a 52-week high of $56.00 and a 52-week low of $10.12.

Can Indians buy Avidity Biosciences shares?

Yes, Indians can invest in the Avidity Biosciences (RNA) from India.

With INDmoney, you can buy Avidity Biosciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Avidity Biosciences at zero transaction cost.

How can I buy Avidity Biosciences shares from India?

It is very easy to buy Avidity Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Avidity Biosciences be purchased?

Yes, you can buy fractional shares of Avidity Biosciences with INDmoney app.

What are the documents required to start investing in Avidity Biosciences stocks?

To start investing in Avidity Biosciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.